ARCHIVES

Galeterone Shows Potential In CRPC AR Variants, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Flood Mistrial

February 9, 1979

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

DeVita Considers Laetrile Tests

June 3, 1977

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Capitol Hill: Mammography Quality standards Act Reintroduced

April 18, 1997